What are the different subtypes of Membranoproliferative Glomerulonephritis (MPGN)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Modern Classification of MPGN Subtypes

MPGN is no longer classified by the old electron microscopy-based system (Types I, II, III), but instead by three distinct immunofluorescence patterns that guide diagnosis and treatment: immune complex-mediated, complement-dominant, and immunofluorescence-negative. 1

The Three Primary Subtypes Based on Immunofluorescence

1. Immune Complex-Mediated MPGN (Immunoglobulin-Positive)

This subtype shows immunoglobulin deposits with or without complement on biopsy and is further subdivided based on whether the immunoglobulin shows monoclonal or polyclonal restriction 1:

Monoclonal Restriction Pattern:

  • Plasma cell disorders 1
  • Monoclonal gammopathy of undetermined significance (MGUS) 1
  • Proliferative GN with monoclonal immune deposits (PGNMID) - notably, a clonal process is found in only 30% of these cases 1
  • Chronic lymphocytic leukemia (CLL) and lymphoma 1

Polyclonal Immune Complex Deposition:

Infectious causes:

  • Hepatitis B and C (including HCV-associated mixed cryoglobulinemia) 1
  • Bacterial endocarditis and infected ventriculo-atrial shunts 1
  • Chronic microbial infections (fungal, parasitic, protozoal, mycoplasma, mycobacterial) 1
  • Visceral abscesses, leprosy, meningococcal meningitis 1

Autoimmune disorders:

  • Systemic lupus erythematosus (SLE) 1
  • Sjögren syndrome 1
  • Rheumatoid arthritis 1
  • Mixed connective tissue disease 1

Other causes:

  • Castleman disease 1
  • Cystic fibrosis, celiac disease 1
  • Sickle cell disease, sarcoidosis 1
  • α1-Antitrypsin deficiency 1

2. Complement-Dominant MPGN (Immunoglobulin-Negative, Complement-Positive)

This pattern shows complement deposition without immunoglobulins and indicates dysregulation of the alternative complement pathway 1:

C3 Glomerulopathy (C3G):

  • C3 glomerulonephritis (C3 GN) 1
  • Dense deposit disease (DDD) - formerly called MPGN Type II 1

Pathogenic mechanisms include:

In children:

  • Genetic mutations in C3, complement factors H, I, B 1
  • CD46 (membrane cofactor protein) mutations 1
  • Complement factor H-related proteins (CFHR) 1-5 mutations 1

In adults:

  • Autoantibodies to C3 convertase (C3 nephritic factor/C3NeF) 1
  • Anti-factor H antibodies 1

Critical diagnostic caveat: Infection-related GN or post-infectious GN must be ruled out before assigning the diagnosis of C3 glomerulopathy, as infections can trigger underlying complement abnormalities 1

3. Immunofluorescence-Negative MPGN (Immunoglobulin-Negative, Complement-Negative)

This pattern shows neither immunoglobulin nor complement deposits and predominantly reflects vascular diseases 1:

  • Thrombotic microangiopathies (TMA) 1
  • Thrombotic thrombocytopenic purpura (TTP) 1
  • Hemolytic uremic syndrome (HUS) 1
  • Sickle cell disease 1
  • Scleroderma 1
  • Transplant glomerulopathy 1
  • Antiphospholipid syndrome 1
  • Malignant hypertension 1

Why the Old Classification System Was Abandoned

The historical electron microscopy-based classification (Types I, II, III) lacked specificity for underlying diagnosis and did not help delineate the underlying cause or guide treatment 1. Light microscopy findings of basement membrane duplication ("tram-tracking") and lobular appearance, while characteristic, occur across multiple etiologies 1. The modern immunofluorescence-based system directly correlates with distinct pathogenetic mechanisms and guides appropriate workup and treatment 1.

Essential Workup Based on Subtype

For immune complex-mediated MPGN with monoclonal restriction:

  • Serum and urine protein electrophoresis with immunofixation 1
  • Serum free light chain analysis 1
  • Hematology consultation for evaluation of clonal process 1

For complement-dominant MPGN:

  • Comprehensive complement analysis even in the absence of hypocomplementemia 1
  • Genetic screening in children for complement mutations 1
  • Testing for C3NeF and anti-factor H antibodies in adults 1

For all MPGN patterns:

  • Extensive workup for secondary causes before labeling as "idiopathic" 1
  • Evaluation for plasma cell dyscrasias 1

True idiopathic MPGN is rare and will likely become even rarer as additional underlying disease mechanisms are identified 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.